Search Results - Shuzo Tashima

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Features of patients who developed hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C Virus

    Features of patients who developed hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C Virus by Mawatari, Seiichi, Kumagai, Kotaro, Oda, Kohei, Tabu, Kazuaki, Ijuin, Sho, Fujisaki, Kunio, Tashima, Shuzo, Inada, Yukiko, Uto, Hirofumi, Saisyoji, Akiko, Hiramine, Yasunari, Hashiguchi, Masafumi, Tamai, Tsutomu, Hori, Takeshi, Taniyama, Ohki, Toyodome, Ai, Sakae, Haruka, Kure, Takeshi, Sakurai, Kazuhiro, Moriuchi, Akihiro, Kanmura, Shuji, Ido, Akio

    Published in PloS one
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Features of patients who developed hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C Virus

    Features of patients who developed hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C Virus by Seiichi Mawatari, Kotaro Kumagai, Kohei Oda, Kazuaki Tabu, Sho Ijuin, Kunio Fujisaki, Shuzo Tashima, Yukiko Inada, Hirofumi Uto, Akiko Saisyoji, Yasunari Hiramine, Masafumi Hashiguchi, Tsutomu Tamai, Takeshi Hori, Ohki Taniyama, Ai Toyodome, Haruka Sakae, Takeshi Kure, Kazuhiro Sakurai, Akihiro Moriuchi, Shuji Kanmura, Akio Ido

    Published in PloS one
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    SAT-247-The evaluation of the inhibitory effect of oral anti-hepatitis C virus agents on carcinogenesis

    SAT-247-The evaluation of the inhibitory effect of oral anti-hepatitis C virus agents on carcinogenesis by Mawatari, Seiichi, Moriuchi, Akihiro, Tashima, Shuzo, Kasai, Ai, Ijuin, Sho, Tabu, Kazuaki, Oda, Kohei, Ido, Akio

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Sustained virologic response after eight weeks of treatment with sofosbuvir, ledipasvir, and ribavirin in a decompensated cirrhotic patient with hepatitis C virus genotype 1b

    Sustained virologic response after eight weeks of treatment with sofosbuvir, ledipasvir, and ribavirin in a decompensated cirrhotic patient with hepatitis C virus genotype 1b by Taniyama, Ohki, Mawatari, Seiichi, Oda, Kohei, Tabu, Kazuaki, Ijuin, Sho, Kumagai, Kotaro, Kasai, Ai, Tashima, Shuzo, Tamai, Tsutomu, Moriuchi, Akihiro, Ido, Akio

    Published in Hepatology research
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Sustained virologic response after eight weeks of treatment with sofosbuvir, ledipasvir, and ribavirin in a decompensated cirrhotic patient with hepatitis C virus genotype 1b

    Sustained virologic response after eight weeks of treatment with sofosbuvir, ledipasvir, and ribavirin in a decompensated cirrhotic patient with hepatitis C virus genotype 1b by Taniyama, Ohki, Mawatari, Seiichi, Oda, Kohei, Tabu, Kazuaki, Ijuin, Sho, Kumagai, Kotaro, Kasai, Ai, Tashima, Shuzo, Tamai, Tsutomu, Moriuchi, Akihiro, Ido, Akio

    Get full text
    Report
    Save to List
    Saved in:

Search Tools: